Work

The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer

Year: 1999

Type: article

Source: Oncogene

DOI: 10.1038/sj.onc.1202909

Authors: J Kleeff, T Ishiwata, H Maruyama, H Friess, P Truong, M W Büchler, D Falb, M Korc

Institutions: University of California, Irvine, University of Bern, Takeda Oncology (United States)

Language: English

Topic: TGF-β signaling in diseases

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Theodor Bilharz Research Institute, University of California, Irvine, National Cancer Institute

Award: G1343625746

OpenAlex ID: W2031556612

FWCI: 4.309

Cites: 54

Cited by: 258

Related to: 10